From: Identifying genetic networks underlying myometrial transition to labor
Increased gestation pattern group | Gene symbol | Fold-change at 14 days |
---|---|---|
Prostaglandin and cortisol synthesis | Â | Â |
Hydroxysteroid 11-beta dehydrogenase 1 | Hsd11b1 | 10.6 |
Decidual/trophoblast prolactin-related protein | Dtprp | 6.2 |
Hydroxysteroid 11-beta dehydrogenase 2 | Hsd11b2 | 3.6 |
Cytochrome P450, 11a | Cyp11a1 | 2.3 |
Prostaglandin-endoperoxide synthase 1 | Ptgs1 | 2.0 |
Phospholipase inhibition | Â | Â |
Annexin A8 | Anxa8 | 4.4 |
Annexin A3 | Anxa3 | 3.1 |
Uteroglobin | Utg | 2.7 |
Calpactin | S100a10 | 2.5 |
Annexin A1 | Anxa1 | 2.4 |
Annexin A2 | Anxa2 | 2.1 |
Proteolysis and peptidolysis | Â | Â |
Kidney-derived aspartic protease-like protein | Kdap | 8.2 |
CTLA-2-beta | Ctla2b | 8.1 |
Cathepsin Z | Ctsz | 3.1 |
Dipeptidase 1 | Dpep1 | 3.1 |
Procollagen C-proteinase enhancer protein | Pcolce | 2.6 |
Lipocalin 7 | Lcn7 | 2.6 |
Serine-type endopeptidases | Â | Â |
Granzyme G | Gzmg | 71.4 |
Granzyme D | Gzmd | 45.7 |
Granzyme F | Gzmf | 40.2 |
Granzyme E | Gzme | 19.8 |
Granzyme C | Gzmc | 10.7 |
RIKEN cDNA 2210021K23 gene | 2210021K23Rik | 2.9 |
Cathepsin G | Ctsg | 2.2 |
Protease, serine, 11 (Igf binding) | Prss11 | 2.2 |
Granzyme B | Gzmb | 2.1 |
Protease inhibitors | Â | Â |
Tissue factor pathway inhibitor 2 | Tfpi2 | 4.2 |
Serine protease inhibitor 14 | Serpinb9e | 3.3 |
Plasma protease C1 inhibitor | Serping1 | 2.7 |
Extracellular matrix remodeling and cell growth | Â | Â |
Regulation of cell growth | Â | Â |
Insulin-like growth factor binding protein 2 | Igfbp2 | 12.4 |
Interleukin 1 receptor, type II | Il1r2 | 5.0 |
Glucocorticoid-induced leucine zipper | Gilz | 3.8 |
Tumor necrosis factor, alpha-induced protein 2 | Tnfaip2 | 3.3 |
c-Fos induced growth factor | Figf | 3.2 |
Related RAS viral (r-ras) oncogene homolog 2 | Rras2 | 3.0 |
Cysteine rich protein 2 | Crip2 | 2.9 |
MORF-related gene X | Morf4l2 | 2.6 |
Epithelial membrane protein 1 | Emp1 | 2.5 |
Four and a half LIM domains 1 | Fhl1 | 2.3 |
S100 calcium binding protein A6 (calcyclin) | S100a6 | 2.3 |
Insulin-like growth factor binding protein 6 | Igfbp6 | 2.1 |
Transforming growth factor, beta 2 | Tgfb2 | 2.0 |
Integrin-mediated signaling pathway | Â | Â |
Secreted phosphoprotein 1 | Spp1 | 17.3 |
Connective tissue growth factor | Ctgf | 2.8 |
Caveolin, caveolae protein | Cav | 2.5 |
Ras homolog gene family, member A2 | Arha | 2.4 |
Structural constituent of cytoskeleton | Â | Â |
Gelsolin | Gsn | 2.4 |
Tropomyosin 4 | Tpm4 | 3.1 |
Tubulin, beta 2 | Tubb2 | 2.2 |
Extracellular matrix structural constituent | Â | Â |
Microfibrillar associated protein 5 | Mfap5-pending | 6.9 |
Elastin | Eln | 3.1 |
Procollagen, type XI, alpha 1 | Col11a1 | 3.0 |
Fibromodulin | Fmod | 2.4 |
Fibrillin 1 | Fbn1 | 2.3 |
Procollagen, type V, alpha 2 | Col5a2 | 2.2 |
Laminin, gamma 1 | Lamc1 | 2.2 |
Procollagen, type I, alpha 2 | Col1a2 | 2.2 |
G-protein signaling | Â | Â |
Guanylate cyclase activator 2b | Guca2b | 15.2 |
Chemokine orphan receptor 1 | Cmkor1 | 5.0 |
Adrenomedullin | Adm | 2.0 |
Guanine nucleotide binding protein, gamma 11 | Gng11 | 2.0 |
Transcriptional regulation | Â | Â |
Secreted frizzled-related sequence protein 4 | Sfrp4 | 4.2 |
Kruppel-like factor 4 | Klf4 | 3.0 |
C/EBP delta | Cebpd | 2.3 |
Inhibitor of DNA binding 1 | Idb1 | 2.1 |
X-box binding protein 1 | Xbp1 | 2.0 |
Kruppel-like factor 2 | Klf2 | 2.0 |